Colorectal Cancer Is Borrowing Blueprints from Intestinal Ontogenesis

Area of Science:

• Molecular biology
• Cancer research
• Developmental biology

Background:

• Colorectal tumors contain heterogeneous cancer stem cells (CSCs) crucial for tumor initiation and growth.
• Understanding CSC emergence mechanisms is vital for effective colorectal cancer (CRC) therapies.
• Aberrant stem cells in preneoplastic lesions share transcriptional similarities with fetal gut development.

Purpose of the Study:

• To explore the role of developmental gene expression programs in colorectal cancer stemness.
• To identify therapeutic targets for suppressing pro-oncogenic stem cell populations in CRC.
• To integrate findings from developmental pathways and chemical genomics for novel therapeutic strategies.

Main Methods:

• Identification of aberrant stem cells in preneoplastic intestinal lesions.
• Analysis of transcriptional similarities with fetal gut development.
• Application of chemical genomics to identify FDA-approved drugs targeting neoplastic self-renewal.

Main Results:

• Sox9 identified as a key factor in altered cell plasticity, premalignant stemness, and colorectal tumor initiation.
• Transcriptional programs related to fetal development are implicated in CSCs.
• FDA-approved drugs identified for suppressing neoplastic self-renewal based on developmental pathways.

Conclusions:

• Developmental gene expression programs are critical targets for suppressing colorectal cancer stemness.
• Sox9 plays a fundamental role in maintaining CSC properties and tumor initiation.
• Integrating developmental networks and chemical genomics offers a novel paradigm for CRC therapeutics.